Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials.
| Autor: | Sengsayadeth, S1, Savani, B N1, Jagasia, M1, Goodman, S1, Greer, J P1, Chen, H2, Chinratanalab, W1, Kassim, A A1, Engelhardt, B G1 |
|---|---|
| Zdroj: | Bone Marrow Transplantation. Feb2014, Vol. 49 Issue 2, p236-240. 5p. 1 Diagram, 2 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|